Literature DB >> 18063505

Dermatitis herpetiformis and vitiligo.

Ozlem Karabudak1, Bilal Dogan, Sukru Yildirim, Yavuz Harmanyeri, Rana Anadolu-Brasie.   

Abstract

Dermatitis herpetiformis (DH) is a rare immunobullous disorder of the skin that is associated with gluten hypersensitivity. Subepidermal IgA-type antibody deposition against tissue transglutaminase leads to dense neutrophilic microabscess and eventually into vesicles in dermal papillae, which may occasionally merge into bullae. Being a subepidermal vesiculobullous disorder, DH is frequently associated with postinflammatory pigmentary changes, particularly hypopigmentation. However, the association of DH with true vitiligo is extremely rare. Here, we report a 21-year-old male with vitiligo and comorbid DH, and review the literature. This new case had severely pruritic, papular and papulovesicular lesions that were localized symmetrically and partly confined to the pre-existing vitiliginous areas. The skin biopsy specimen taken from an erythematous papule on the elbow showed characteristic findings of DH and vitiligo. Direct immunofluorescence microscopy of the perilesional skin revealed granular IgA deposition of dermal papillae. There are only 10 reports in the literature of DH and vitiligo comorbidity.

Entities:  

Mesh:

Year:  2007        PMID: 18063505     DOI: 10.1016/S1726-4901(08)70049-2

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN: 1726-4901            Impact factor:   2.743


  3 in total

1.  Celiac disease of the joint.

Authors:  Ozden Ozyemisci-Taskiran; Mustafa Cengiz; Fatma Atalay
Journal:  Rheumatol Int       Date:  2010-12-09       Impact factor: 2.631

2.  Vitiligo at Injection Site of PEG-IFN-α 2a in Two Patients with Chronic Hepatitis C: Case Report and Literature Review.

Authors:  V Arya; M Bansal; L Girard; S Arya; A Valluri
Journal:  Case Rep Dermatol       Date:  2010-08-27

Review 3.  Association between celiac disease and vitiligo: A review of the literature.

Authors:  Jing-Zhan Zhang; Dilinuer Abudoureyimu; Man Wang; Shi-Rong Yu; Xiao-Jing Kang
Journal:  World J Clin Cases       Date:  2021-12-06       Impact factor: 1.337

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.